ArticleBMC ophthalmology2025
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation associated with KIF11 pathogenic variant: case report and genotype-phenotype correlation analysis.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Choroidal imaging features of KIF11-associated retinopathy: expanding the ocular phenotype.International journal of retina and vitreous · 2026Article
- Non-transport functions of motor proteins in corticogenesis.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicrocephaly with or without chorioretinopathy, lymphedema, or mental retardation (MCLMR) is a rare autosomal dominant disease caused by variants in the KIF11 gene. Additionally, recent advances in genetic testing have led to the increasing identification of KIF11 gene variants in FEVR patients. Harboring similar point variants in the KIF11 gene, patients exhibit striking variability in clinical manifestations. However, comprehensive clinical characterization of MCLMR patients with KIF11 variants are only mentioned by a few case reports and the genotypic and phenotypic variability in KIF11-associated disease was not thoroughly investigated. Therefore, one case is discussed alongside a systematic review of published MCLMR cases to clarify genotype-phenotype correlations. CASE PRESENTATION: An 8-year-old boy was referred to our clinic due to poor vision. Clinical evaluation revealed microcephaly, characteristic chorioretinopathy and mild developmental delay, in the absence of primary lymphedema. Additional findings included special facial features, bilateral simian crease and metabolic abnormalities featuring elevated urine glucose and ketone bodies despite normoglycemia. Brain magnetic resonance imaging (MRI) demonstrated microcephaly with simplified gyration, delayed myelination, and cortical thickening. Whole exome sequencing (WES) identified a previously reported synonymous variant in KIF11 (c.2922G > A, p.Pro974=), which was confirmed and co-segregated by Sanger sequencing.
conclusionsA Chinese boy was diagnosed with MCLMR following the identification of a pathogenic KIF11 gene point variant, as classified according to ACMG guidelines. Combined with previously reported literature, a total of 55 pathogenic KIF11 variants have been identified, distributed throughout the entire gene. A recurrent mutational hotspot (c.1159 C > T, p.Arg238*) was observed. Additionally, frameshift and splicing variants collectively account for over 50% of cases. Notably, missense variants are associated with more severe phenotypic manifestations, suggesting a genotype-phenotype correlation. This case, supported by comprehensive clinical data, contributes to a more complete elucidation of the phenotypic spectrum of KIF11-related disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.